Explore more publications!

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on November 26, 2025

 Al Barari crowns its legacy with The Cape, the final masterpiece in Dubai’s greenest community
Outdoor Bar Stools Redefine Modern Living Spaces in Dubai’s Evolving Outdoor Culture
WHX Labs in Dubai to celebrate 25 years of innovation as part of the world’s largest healthcare gathering in 2026
YRC Advises International Retailers on Successful Market Entry into Nigeria, Kenya, and UAE
Openmind Networks Joins GSMA Open Gateway as Channel Partner to Accelerate Global Adoption of CAMARA and OneAPI
Bell Integration Expands Agentic AI Consulting Services into the U.A.E.
K Soft Website by Pinar Bahar Wins Silver in A' Website and Web Design Awards
Drydocks World Dubai pioneers world’s first IOSH-approved virtual reality safety training
cell happy co, a Leading K-Beauty Brand, Gains Attention in Europe with Three COSMOS Organic-Certified Products
The Binary Holdings Wins Emerging Tech Award at Inc. Arabia's Best in Business 2025
Ooredoo Qatar and LigaData Build Trusted Data Foundations for AI Innovation
Air Chief by Korkmaz Mutfak Esyalari Wins Silver in A' Home Appliances Design Award
Squaretalk and EAERA Collaborate to Provide Seamless Communication and Faster Conversions for Forex Brokers Worldwide
FY2025 Marks Remarkable Milestone for Thailand, Securing 30 Int’l Large-Scale Events Across MICE Sectors and Mega-Event
Significant Reduction in Wrinkling for Thobe Construction HIKARI Resolve Traditional Arab Garment Challenges
MONITORAPP Partners With Webnet Ally to Strengthen Presence in the Middle East
Hamad International Airport’s Virtual Tower Goes Into Operation
ESET to Showcase Advanced Cybersecurity Solutions at Black Hat MEA 2025
Teva erhält Zulassung der Europäischen Kommission für PONLIMSI® (Denosumab), ein Biosimilar zu Prolia®, und DEGEVMA® (Denosumab), ein Biosimilar zu Xgeva®
Teva obtient les autorisations de la Commission européenne pour PONLIMSI® (dénosumab), biosimilaire de Prolia® et DEGEVMA® (dénosumab), biosimilaire de Xgeva®

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions